Paul K Wotton
CEO, Obsidian
Wotton has experience spanning scientific research, product development, and corporate growth accumulated over a 30-year career. He most recently served as the founding President and CEO of Sigilon Therapeutics. In previous roles, he served as president and CEO of Antares Pharma as well as CEO of Topigen Pharmaceuticals. He is a named inventor on numerous patents and was the Ernst & Young Entrepreneur of the Year Regional (NJ) Winner Life Sciences in 2014.
What is the most interesting or little-known fact about you?
In a past life I was a window cleaner.
What is the biggest lesson the industry has learned during the COVID-19 pandemic?
How to adapt within a rapidly changing environment to collaborate more effectively with other companies, regulatory bodies, and individuals.